Mangoceuticals On Dec. 10, Entered Into A Marketing Agreement With Marius Pharmaceuticals; Agreement Allowing Co The Use Of Trademark "Kyzatrex" Oral Testosterone Undecanoate Softgel Capsules; Agreement Allowing Co Selling Kyzatrex On Their Website
Portfolio Pulse from Benzinga Newsdesk
Mangoceuticals has entered into a marketing agreement with Marius Pharmaceuticals, according to a Dec. 10 SEC 8K filing. The agreement grants Mangoceuticals the rights to use the trademark 'Kyzatrex' for oral testosterone undecanoate softgel capsules and allows them to sell Kyzatrex on their website.
December 11, 2023 | 9:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mangoceuticals has obtained marketing rights for 'Kyzatrex' from Marius Pharmaceuticals, which could potentially increase their product offerings and revenue.
The marketing agreement with Marius Pharmaceuticals allows Mangoceuticals to use the 'Kyzatrex' trademark and sell the product on their website, which could lead to increased visibility and sales for Mangoceuticals. This partnership is likely to be viewed positively by investors, as it expands the company's product portfolio and market presence.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 80